Eugene P. Kennedy - 01 Sep 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Medical Officer
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Eugene P. Kennedy
Issuer symbol
GRTX
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4
Filing time
02 Sep 2022, 16:15:12 UTC
Next filing
28 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 01 Sep 2022 Common Stock 150,000 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% on September 1, 2023, and in thirty-six (36) substantially equal monthly installments over a three-year period thereafter.